These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21900107)

  • 1. Flaxseed and breast cancer: what should we tell our patients?
    Patterson RE
    J Clin Oncol; 2011 Oct; 29(28):3723-4. PubMed ID: 21900107
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediagnostic plasma enterolactone levels and mortality among women with breast cancer.
    Olsen A; Christensen J; Knudsen KE; Johnsen NF; Overvad K; Tjønneland A
    Breast Cancer Res Treat; 2011 Aug; 128(3):883-9. PubMed ID: 21340481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum enterolactone and prognosis of postmenopausal breast cancer.
    Buck K; Vrieling A; Zaineddin AK; Becker S; Hüsing A; Kaaks R; Linseisen J; Flesch-Janys D; Chang-Claude J
    J Clin Oncol; 2011 Oct; 29(28):3730-8. PubMed ID: 21900115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status.
    Zaineddin AK; Vrieling A; Buck K; Becker S; Linseisen J; Flesch-Janys D; Kaaks R; Chang-Claude J
    Int J Cancer; 2012 Mar; 130(6):1401-10. PubMed ID: 21544804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study.
    Guglielmini P; Rubagotti A; Boccardo F
    Breast Cancer Res Treat; 2012 Apr; 132(2):661-8. PubMed ID: 22094938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis.
    Seibold P; Vrieling A; Johnson TS; Buck K; Behrens S; Kaaks R; Linseisen J; Obi N; Heinz J; Flesch-Janys D; Chang-Claude J
    Int J Cancer; 2014 Aug; 135(4):923-33. PubMed ID: 24436155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum enterolactone levels and the risk of breast cancer in women with palpable cysts.
    Boccardo F; Lunardi G; Guglielmini P; Parodi M; Murialdo R; Schettini G; Rubagotti A
    Eur J Cancer; 2004 Jan; 40(1):84-9. PubMed ID: 14687793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enterolactone and coronary events.
    Bonnet F; Gilbert R
    Lancet; 2000 May; 355(9215):1642-3. PubMed ID: 10821384
    [No Abstract]   [Full Text] [Related]  

  • 9. Short-term variations in enterolactone in serum, 24-hour urine, and spot urine and relationship with enterolactone concentrations.
    Stumpf K; Adlercreutz H
    Clin Chem; 2003 Jan; 49(1):178-81. PubMed ID: 12507978
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma enterolactone and genistein and the risk of premenopausal breast cancer.
    Piller R; Chang-Claude J; Linseisen J
    Eur J Cancer Prev; 2006 Jun; 15(3):225-32. PubMed ID: 16679865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study.
    Kilkkinen A; Virtamo J; Vartiainen E; Sankila R; Virtanen MJ; Adlercreutz H; Pietinen P
    Int J Cancer; 2004 Jan; 108(2):277-80. PubMed ID: 14639615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of flaxseed supplementation in processed foods on serum fatty acids and enterolactone.
    Tarpila S; Aro A; Salminen I; Tarpila A; Kleemola P; Akkila J; Adlercreutz H
    Eur J Clin Nutr; 2002 Feb; 56(2):157-65. PubMed ID: 11857049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the time-resolved fluoroimmunoassay of plasma enterolactone.
    Stumpf K; Uehara M; Nurmi T; Adlercreutz H
    Anal Biochem; 2000 Aug; 284(1):153-7. PubMed ID: 10933868
    [No Abstract]   [Full Text] [Related]  

  • 14. Human metabolism of mammalian lignan precursors in raw and processed flaxseed.
    Nesbitt PD; Lam Y; Thompson LU
    Am J Clin Nutr; 1999 Mar; 69(3):549-55. PubMed ID: 10075344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary flaxseed and tamoxifen affect the inflammatory microenvironment in vivo in normal human breast tissue of postmenopausal women.
    Lindahl G; Abrahamsson A; Dabrosin C
    Eur J Clin Nutr; 2019 Sep; 73(9):1250-1259. PubMed ID: 30692654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genistein and enterolactone in relation to Ki-67 expression and HER2 status in postmenopausal breast cancer patients.
    Jaskulski S; Jung AY; Rudolph A; Johnson T; Thöne K; Herpel E; Sinn P; Chang-Claude J
    Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28734033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.
    Pietinen P; Stumpf K; Männistö S; Kataja V; Uusitupa M; Adlercreutz H
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):339-44. PubMed ID: 11319174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma enterolactone and breast cancer incidence by estrogen receptor status.
    Olsen A; Knudsen KE; Thomsen BL; Loft S; Stripp C; Overvad K; Møller S; Tjønneland A
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2084-9. PubMed ID: 15598765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An incident case-referent study on plasma enterolactone and breast cancer risk.
    Hultén K; Winkvist A; Lenner P; Johansson R; Adlercreutz H; Hallmans G
    Eur J Nutr; 2002 Aug; 41(4):168-76. PubMed ID: 12242585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo.
    Bergman Jungeström M; Thompson LU; Dabrosin C
    Clin Cancer Res; 2007 Feb; 13(3):1061-7. PubMed ID: 17289903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.